Cite
APA Citation
Lassman, A. B., Sepúlveda-Sánchez, J. M., Cloughesy, T., Gil-Gil, J. M., Puduvalli, V. K., Raizer, J., De Vos, F. Y., Wen, P. Y., Butowski, N., Clement, P., Groves, M. D., Belda-Iniesta, C., Steward, K., Moran, S., Ye, Y., & Roth, P. (n.d.). oS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study. Neuro-oncology, 21, iii21–iii22. http://access.bl.uk/ark:/81055/vdc_100126060972.0x00000f